Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07034781
PHASE1

A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults

Sponsor: AJU Pharm Co., Ltd.

View on ClinicalTrials.gov

Summary

To Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults

Official title: An Open-label, 2-arm, Single-sequence, Single Oral Dosing, Crossover Clinical Trial to Evaluate Safety and the Pharmacokinetics Between Dapagliflozin, Linagliptin and Metformin in Healthy Adult Subjects

Key Details

Gender

All

Age Range

19 Years - 50 Years

Study Type

INTERVENTIONAL

Enrollment

50

Start Date

2025-08

Completion Date

2025-11

Last Updated

2025-06-24

Healthy Volunteers

Yes

Interventions

DRUG

Comparator 1

Dapagliflozin 10mg + Linagliptin 5mg

DRUG

Comparator 2

Metformin 1000mg

DRUG

Test Drug

Fixed-dose combination tablet (AJU-A53)

Locations (1)

Chung-Ang University Gwangmyeong Hospital

Gwangmyeong, Gyeonggi-do, South Korea